Development of various
molecular laser isotope separation (MLIS) variants began in the 1970s. The key physical process in all of them is an infrared laser, which vibrationally excites only one of the isotopes in gaseous
uranium hexafluoride. This requires a wavelength near 16 μm. Traditional MLIS then continued to excite the molecules unto
dissociation, at which point they crystallized as
uranium-235 pentafluoride. After initial euphoria, laser isotope separation research was mostly abandoned during the 1990s, mainly because it still required extensive and uncertain research and development work, while
gas centrifuges had reached
technological maturity. However, Australia continued research on the SILEX technique. In November 1996, Silex Systems Limited licensed its technology exclusively to
United States Enrichment Corporation (USEC) for uranium enrichment. In 1999, the United States and Australia signed an international treaty for cooperative SILEX research and development. However, in 2003 USEC backed out from the project. Silex Systems concluded the second stage of testing in 2005 and began its Test Loop Program. In 2007, Silex Systems signed an exclusive commercialization and licensing agreement with
General Electric Corporation (GE), transferring their test loop to GE's facility in
Wilmington, North Carolina. That year,
GE Hitachi Nuclear Energy (GEH) signed
letters of intent for uranium enrichment services with
Exelon and
Entergy - the two largest nuclear power utilities in the USA. In 2008, GEH spun off Global Laser Enrichment (GLE) to commercialise the SILEX Technology and announced the first potential commercial uranium enrichment facility using the Silex process. The U.S.
Nuclear Regulatory Commission (NRC) approved a license amendment allowing GLE to operate the Test Loop. Also in 2008,
Cameco Corporation, Canada, the world's largest uranium producer, joined GE and Hitachi as a part owner of GLE. In 2010, concerns were raised that the SILEX process poses a threat to global nuclear security. Between 2011 and 2012, GLE applied for and received a permit to build a commercial enrichment plant at Wilmington. The plant would enrich uranium to 8% 235U, the upper end of
low-enriched uranium. In 2014, both GLE and Silex Systems restructured, with Silex halving its workforce. In 2016, the
United States Department of Energy agreed to sell about 300,000 tonnes of
depleted uranium hexafluoride to GLE for re-enrichment (from 0.35 to 0.7 % 235U) using the SILEX process over 40 years at a proposed
Paducah, Kentucky Laser Enrichment Facility. In 2018, Silex Systems abandoned its plans for GLE, intending to repatriate the SILEX technology to Australia. In 2021, Silex Systems took majority ownership (51%) of GLE, with Cameco (49%) as minority owner. Under an agreement between GLE and the US Department of Energy, GLE will re-enrich to natural levels several hundred kilotons of
depleted uranium tailings from the
last enrichment plant to use
gaseous diffusion. That plant operated in Paducah until 2013, and GLE plans to build their new plant on the same spot. ==Process==